Bendamustine in combination with gemcitabine and vinorelbine as salvage regimen for relapsed or refractory peripheral T‐cell lymphomas: A retrospective single‐centre experience

Ähnliche Einträge

• Reduced incidence of relapse after checkpoint inhibitors relative to brentuximab vedotin as salvage therapy before allogeneic stem cell transplantation for refractory/relapsed Hodgkin lymphoma: A retrospective analysis
  von: Jacopo Mariotti, et al.
  Veröffentlicht: (2025)
• Pembrolizumab and pralatrexate for relapsed or refractory peripheral T‐cell lymphomas
  von: Christina Poh, et al.
  Veröffentlicht: (2026)
• Safety and effectiveness of mogamulizumab in relapsed or refractory CC chemokine receptor 4‐positive peripheral T‐cell lymphoma and relapsed or refractory cutaneous T‐cell lymphoma: A post‐marketing surveillance in Japan
  von: Kenji Ishitsuka, et al.
  Veröffentlicht: (2024)
• Golidocitinib and chidamide for refractory or relapsed peripheral T‐cell lymphoma: A preliminary cost‐effectiveness analysis in China
  von: Tianyu Jing, et al.
  Veröffentlicht: (2025)
• Nivolumab plus ifosfamide, carboplatin, and etoposide are a highly effective first salvage regimen in high‐risk relapsed/refractory Hodgkin lymphoma
  von: Matthew Mei, et al.
  Veröffentlicht: (2025)